MML Investors Services
ACAD icon

MML Investors Services’s Acadia Pharmaceuticals ACAD Stock Holding History

MML Investors Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$813K Buy
36,523
+3,786
+12% +$90.5K ﹤0.01% 1906
2025
Q4 		$874K Buy
32,737
+10,426
+47% +$249K ﹤0.01% 1890
2025
Q3 		$476K Buy
22,311
+6,127
+38% +$145K ﹤0.01% 2205
2025
Q2 		$349K Buy
16,184
+5,382
+50% +$100K ﹤0.01% 2322
2025
Q1 		$179K Buy
+10,802
New +$196K ﹤0.01% 2569

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

MML Investors Services's ACAD Position: Q1 2026 in Review

MML Investors Services increased its Acadia Pharmaceuticals (ACAD) stake by 12% in Q1 2026, buying an estimated $90.5K and bringing the position to 36,523 shares worth $813K. The position accounts for ﹤0.01% of the portfolio, ranked #1906.

MML Investors Services first reported a position in ACAD in Q1 2025 and has held it in 5 quarters since. The position peaked at $874K in Q4 2025. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • MML Investors Services held 36,523 shares of Acadia Pharmaceuticals worth $813K as of Q1 2026.
  • MML Investors Services bought 3,786 Acadia Pharmaceuticals shares in Q1 2026, an estimated $90.5K.
  • Acadia Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q1 2026, its #1906 holding.
  • MML Investors Services first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • MML Investors Services's Acadia Pharmaceuticals position peaked at $874K in Q4 2025.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.